Skip to content

Clinical trials

Phase 2 Hemorrhagic Stroke trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Stroke Phase: Phase 2 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20101
20123
20171
20191
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital Heidelberg4
Bellus Health Inc. - a GSK company1
Nanjing University of Traditional Chinese Medicine1
Novartis Pharmaceuticals1
University of Kansas Medical Center1
University of Pennsylvania1
University of Washington1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhagic Stroke10
Stroke9
Ischemic Stroke6
Hypothermia4
Cerebrovascular Disorders3
Intracranial Hemorrhages3
Cerebral Amyloid Angiopathy1
Cerebral Hemorrhage1
Emergencies1
Nervous System Diseases1

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.